Re: Kathia De Man, Nick Van Laeken, Vanessa Schelfhout, et al. ¹⁸F-PSMA-11 Versus ⁶⁸Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial. Eur Urol. 2022;82:501-509

Affiliations

¹ Urological Research Institute, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy.
² Urological Research Institute, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy. Electronic address: giorgio.gandaglia@gmail.com.

Comment

Francesco Montorsi et al. Eur Urol. 2022 Nov.

. 2022 Nov;82(5):e143.

doi: 10.1016/j.eururo.2022.07.035. Epub 2022 Aug 19.

¹ Urological Research Institute, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy.
² Urological Research Institute, San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy. Electronic address: giorgio.gandaglia@gmail.com.

No abstract available

Comment on

¹⁸F-PSMA-11 Versus ⁶⁸Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial.
De Man K, Van Laeken N, Schelfhout V, Fendler WP, Lambert B, Kersemans K, Piron S, Lumen N, Decaestecker K, Fonteyne V, Delrue L, De Vos F, Ost P. De Man K, et al. Eur Urol. 2022 Nov;82(5):501-509. doi: 10.1016/j.eururo.2022.05.010. Epub 2022 Jun 8. Eur Urol. 2022. PMID: 35690515 Clinical Trial.